Diagnosis of GIST can be challenging -recent research has shown people with rare cancers are two times more likely than those with common cancers to receive multiple diagnoses before physicians are able to accurately identify their disease 3 . To help get the most information and best advice about their disease, patients with GIST should work with their treating physicians to form personal multidisciplinary teams, which should include a surgeon, oncologist and pathologist 1, 4 .
PRIMARY VS. METASTATIC DISEASE
Primary GIST Although complete surgical removal is possible in most patients with primary GIST, meaning that the tumors are found at the original site of development and have not spread to other locations, it is possible for patients to develop tumor recurrence or metastasis following surgery and survival following recurrence is poor 1 . Median time to recurrence after surgical removal of high-risk primary GIST is about two years 5 .
Metastatic GIST (Advanced GIST)
GIST become metastatic when the tumors spread to distant parts of the body. Data show the 5-year survival rate for these patients at initial diagnosis to be about 13% 1 .
DISEASE INCIDENCE
The exact number of people diagnosed with GIST each year is not known. In the US, the incidence of GIST is estimated to range from about 4,000 to 5,000 cases each year, while in the EU, the incidence of GIST is estimated to be more than 5,000 cases each year 1, 2, 6 .
Most people diagnosed with GIST are older than 50, but these tumors can occur at any age 1 . GIST is slightly more common in men 1 .
DISEASE PROGRESSION
Upon diagnosis, doctors use several means to assess how GIST might progress. Factors they take into account include the size of the tumor, where the primary tumor was found, mitotic rate, tumor rupture and patient demographics 1, 7, 8, 9 .
Mitosis is a type of cell division, and the mitotic rate is a measure of how fast cancer cells are growing and dividing, found by a ratio of the number of cells in mitosis to the total number of cells. In cancer, a high mitotic rate indicates that a tumor is rapidly growing and dividing, and therefore is more aggressive. It is a marker used in other cancers, such as skin cancer, and is discovered by ATP, a cellular coenzyme, binds to a pocket in the mutated KIT causing abnormal cell growth
